Comparison of ATG-Fresenius S to Thymoglobulin in prophylaxis for immunological high risk patients following renal transplantion
01.02.2009
Two poyclonal depleting antibody products as an immunosuppresive induction therapy will be compared regarding safety profile and efficacy in immunological high risk patients after renal transplantion.
1. a regimen consisting of a triple drug therapy...
Klinische Forschung -
01.02.2009 - 31.12.2010
Abgeschlossen
Projektleitung: Binet Françoise-Isabelle
Mitarbeiter/innen: Bucher Christian, Zuercher Ursula
Weiter
